-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROSENSE RECEIVES FDA CLEARANCE TO INITIATE PIVOTAL PHASE 3 TRIAL FOR PRIMEC IN ALS

Reuters·11/24/2025 14:56:55

Please log in to view news